Sotoxen 320 — Sotorasib 320 mg, 90 product-page.units_short, Everest
100% original product

Sotoxen 320 — Sotorasib 320 mg Tablets

71591 75930 -6%

Sotoxen 320 mg (Sotorasib) is a breakthrough targeted therapy and a generic equivalent to Lumakras. It is a first-in-class inhibitor of the KRAS G12C protein, a target that was previously considered "undruggable" in oncology.

Manufacturer: Everest Pharmaceuticals (Bangladesh). The drug is designed to treat non-small cell lung cancer by permanently locking the mutated protein in an inactive state.

Key Features:

  • Mechanism of Action: Specifically targets the KRAS G12C mutation, shutting down the signaling pathway that drives cancer cell growth.
  • High Selectivity: Binds only to the mutated protein without affecting the normal (wild-type) KRAS protein, minimizing damage to healthy cells.
  • Clinical Efficacy: Demonstrates rapid and durable tumor shrinkage in patients who have progressed on prior therapies.

Prescribed by oncologists only after the KRAS G12C mutation is confirmed via testing:

  • 🔹 Non-Small Cell Lung Cancer (NSCLC): Locally advanced or metastatic NSCLC in adult patients.
  • 🔹 Indicated for patients who have received at least one prior systemic therapy (chemotherapy or immunotherapy).

Sales Unit: Bottle with 320 mg tablets.

⚠️ DOSING INSTRUCTIONS:

  • Recommended Dose: 960 mg once daily. This equals taking 3 tablets of 320 mg at the same time.
  • Administration: Swallow tablets whole with water. Can be taken with or without food, preferably at the same time each day.
  • Important: Do not chew, crush, or split the tablets.
  • Missed Dose: If less than 6 hours have passed, take the dose. If more than 6 hours, skip the dose and resume the next day. Do not take 2 doses at once.
  • Interstitial Lung Disease (ILD): Or history of pneumonitis (drug can cause severe lung inflammation).
  • Severe hepatic impairment (liver damage).
  • Pregnancy and breastfeeding.
  • Children (under 18 years of age).
  • Hypersensitivity to Sotorasib.

Regular monitoring of liver function tests (ALT, AST) is mandatory. Potential side effects:

  • 🩸 Hepatotoxicity: Elevated liver enzymes (common).
  • 📉 Gastrointestinal: Diarrhea (very common), nausea, vomiting.
  • 🦴 Musculoskeletal: Muscle or bone pain.
  • ⚠️ Respiratory: Cough or shortness of breath (report new symptoms immediately due to risk of pneumonitis).
Active ingredient
Manufacturer
Everest
Dosage 320 mg
Dosage form Tablets
Tablets per pack 90
100% original product
Delivery across Ukraine
Alternatives

Similar products

Sotoxen 120 120 mg Everest
View
Everest
120 mg 56 tablets
39917 45558
Lucisot 120 mg Lucius
View
Lucius
120 mg 56 tablets
25165 27769
Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00